Literatur
-
1
Brusilow S W, Maestri N E.
Urea cycle disorders: diagnosis, pathophysiology, and therapy.
Adv Pediatr.
1996;
43
127-170
-
2
Feillet F, Leonard J V.
Alternative pathway therapy for urea cycle disorders.
J Inherit Metab Dis.
1998;
21
(Suppl 1)
101-111
-
3
Ferenci P.
Hepatische Enzephalopathie.
Dtsch Med Wochenschr.
2001;
126
76-80
-
4
Kim W H, Park H, Yun C. et al .
Mixture of N-carbamoyl-L-glutamate plus L-arginine can protect rats with liver cirrhosis from acute ammonia intoxication.
J Hepatol.
2001;
35
719-725
-
5
Kircheis G, Nilius R, Held C. et al .
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Hepatology.
1997;
25
1351-1360
-
6
Kircheis G, Wettstein M, Dahl S, Haussinger D.
Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.
Metab Brain Dis.
2002;
17
453-462
-
7
Lee J H, Kim W H, Cho H, Kwak Y S, Kim S, Paik W K.
N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with reduced functional liver mass.
Biochem Biophys Res Commun.
1998;
248
391-394
-
8
Mitzner S, Loock J, Peszynski P. et al .
Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS - a review of clinical, biochemical, and electrophysiological data.
Metab Brain Dis.
2002;
17
463-475
-
9
Rees C J, Oppong K, Al M ardini H, Hudson M, Record C O.
Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial.
Gut.
2000;
47
571-574
-
10
Rutledge S L, Havens P L, Haymond M W, McLean R H, Kan J S, Brusilow S W.
Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism.
J Pediatr.
1990;
116
125-128
-
11
Strauss E, Tramote R, Silva E P. et al .
Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
Hepatogastroenterology.
1992;
39
542-545
-
12
Takashima Y, Koide M, Fukunaga H. et al .
Recovery from marked altered consciousness in a patient with adult-onset type II citrullinemia diagnosed by DNA analysis and treated with a living related partial liver transplantation.
Intern Med.
2002;
41
555-560
-
13
Tarao K, Ikeda T, Hayashi K. et al .
Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
Gut.
1990;
31
702-706
-
14
Tromm A, Griga T, Greving I. et al .
Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Hepatogastroenterology.
2000;
47
473-477
-
15
Wiegand C, Thompson T, Bock G H, Mathis R K, Kjellstrand C M, Mauer S M.
The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities.
J Pediatr.
1980;
96
142-144
Dr. med. Johannes Häberle
Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin
Albert-Schweitzer-Straße 33
48149 Münster
Phone: +49/251/8357737
Fax: +49/251/8356085
Email: haeb@uni-muenster.de
